Alert
Alert

The Board of Pharmacy will NOT contact you by telephone and demand payment of funds for any reason. Please be aware of scammers identifying as board staff and using phone numbers issued to the board.

LABP Logo

Application Process Transparency - CDS License - Facilities

Every person who conducts research with, manufactures, distributes, procures, possesses, prescribes, or dispenses any controlled dangerous substance within this state, including third-party logistics providers, or who proposes to engage in the research, manufacture, distribution, procurement, possession, prescribing, or dispensing of any controlled dangerous substance within this state shall obtain a controlled dangerous substance (CDS) license from the board prior to engaging in such activities. Only persons actually engaged in such activities are required to obtain a CDS license; related or affiliated persons, e.g., stockholder in manufacturing corporation, who are not engaged in such activities, are not required to be licensed. The performance of such activities in the absence of a valid CDS license shall be a violation of R.S. 40:973.

 

Fee: To be paid with the submission of the online application. 

  • CDS-CRX – Correctional Center – $0.00
  • CDS-DIS – Distributor - $50.00
  • CDS-HOS – Hospital - $50.00
  • CDS-HOX – Hospital - $0.00
  • CDS-HTG - Hemp Facility - $20.00
  • CDS-LAB - Laboratory - $20.00
  • CDX-LAX - Laboratory - $0.00
  • CDS-MFR – Manufacturer - $100.00
  • CDS-ROF – Registered Outsourcing Facility - $100.00
  • CDS-SAC – Substance Abuse Clinic - $50.00
  • CDS-SAX – Substance Abuse Clinic - $0.00
  • CDS-TPL – Third Party Logistics Provider - $50.00
  • CDS-WMC – Withdraw Management Clinic - $50.00

 Application: Application for New Louisiana Controlled Dangerous Substance (CDS) License for Facilities. This application is available online through the Online Services Portal.

Application Preview

 Required Attachments (Checklist):

  • Primary License. The primary license(s) must be active at the physical address provided on the application and without any restrictions that would prevent the procuring or possession of controlled dangerous substances. Labs must be certified with the Clinical Laboratory Improvements Amendments (CLIA). Board staff will verify that certification upon receipt of the application.
  • Authority to Conduct Business – A W9 or FEIN letter is required for the legal entity identified as the direct owner. This entity must be registered with the Louisiana Secretary of State when facility is physically located in the state.
  • Indirect Ownership - All facilities are required to disclose ownership using Form 71 ~ Facility Ownership Disclosure Form.
    .

 Board Review: A review of prior actions and criminal history, reported by the applicant, is completed when all documents have been received and payment processed.

 Criminal history may be used as a basis for denial. All factors outlined in LA:R.S. 37:2950 shall be considered.

  Inspection: In the event that there are no matters preventing the issuance, the applicant shall be instructed to contact the pharmacist compliance officer for that part of the state to arrange a site inspection at a mutually agreeable time.

 Issuance: When the compliance officer has verified compliance with the minimum standards, the license will be issued.

 

You may select Apply to start the application process. 

 

Inquiries regarding the Controlled Dangerous Substance License of a facility may be submitted to: